Order Euflexxa® Italian for Clinics

Euflexxa® (Italian) is a sterile 1% sodium hyaluronate viscosupplement supplied as three 2 mL prefilled syringes for professional intra-articular administration. Licensed clinics and healthcare professionals can order Euflexxa Italian 3x2ml packs for structured knee osteoarthritis injection workflows. The Italian package supports standardized treatment-room handling, lot documentation, and series planning for orthopedic, rheumatology, and sports medicine services.

This preparation contains bioengineered, non-avian sodium hyaluronate produced by bacterial fermentation. The ready-to-use syringe format helps procedural teams reduce preparation steps while maintaining sterile technique at the point of care. Med Wholesale Supplies serves licensed clinics with brand-name medical products sourced through vetted distributors and verified supply channels.

Price, Pack Size, and Clinic Ordering

Clinics can sign in to view current Euflexxa price details, volume tiers, and ordering requirements for the Italian-labeled pack. The supplied format is three prefilled syringes, each containing 2 mL, with the product commonly referenced as Euflexxa 10mg/ml 3 x 2ml or Euflexxa 1% sodium hyaluronate. Use the strength and quantity shown during ordering to match your clinic protocol and documentation requirements.

Procurement teams often evaluate Euflexxa injection cost by series requirements, appointment volume, and inventory turnover. Pack-based planning can simplify purchasing because each carton contains the three-syringe configuration used for a typical clinician-directed series. For additional purchasing context, see our clinic-focused discussion of Euflexxa cost drivers for clinics.

Account verification is required before wholesale ordering. After approval, your facility can coordinate US distribution with temperature-controlled handling when required and tracked US delivery. Lead times can vary with allocation and demand, so teams should align orders with appointment schedules, recall windows, and stock rotation practices.

What This Viscosupplement Is Used For

Euflexxa is a hyaluronic acid injection used in professional care for pain associated with osteoarthritis of the knee in appropriate candidates. It is administered into the joint by a trained healthcare professional, not used as a self-administered product. In clinic pathways, it is typically considered when conservative measures have not provided adequate relief and the treating clinician determines that viscosupplementation fits the patient’s care plan.

Hyaluronic acid is a natural component of synovial fluid, the fluid that lubricates and cushions joints. Osteoarthritis can alter the mechanical and biochemical environment of the knee, reducing smooth joint movement and increasing discomfort under load. A viscosupplement injection is intended to supplement the viscoelastic properties of synovial fluid, supporting lubrication and cushioning during movement.

Clinics may use Euflexxa within orthopedic injection services, sports medicine practices, rheumatology clinics, and ambulatory procedure settings. Teams that manage multiple joint-injection lines can browse related orthopedic injections or rheumatology products for broader formulary planning.

Active Ingredient and How It Works

The active component is sodium hyaluronate, a salt form of hyaluronic acid. Euflexxa sodium hyaluronate is non-avian and bioengineered through controlled bacterial fermentation, which supports a consistent molecular profile and avoids avian-source material. The formulation is sterile, transparent, and intended for intra-articular administration under professional aseptic conditions.

The product’s viscosity and elasticity can support predictable syringe handling during knee injection visits. Procedural teams may administer it using landmark-guided or ultrasound-guided techniques according to local training, labeling, and professional standards. The prefilled syringe format also supports consistent preparation steps across multiple exam rooms or injection sessions.

Euflexxa is sometimes described as a hyaluronic acid knee injection, Euflexxa viscosupplement injection, or Euflexxa osteoarthritis injection. These terms refer to the same general clinical class: intra-articular hyaluronic acid products used in knee osteoarthritis care. The brand should still be documented by its exact name, lot number, expiry, and presentation in clinic records.

Italian-Labeled Presentation and Documentation

This pack is the Italian-labeled presentation of Euflexxa. The carton and insert language reflect the Italian market, while the product name, active ingredient, sterile syringe format, and 3 x 2 mL pack configuration remain the key operational identifiers for clinic teams. Staff should ensure that internal records capture the brand, concentration, lot number, expiry, and administration details required by facility policy.

The Italian package may also be called an Euflexxa IT pack in procurement conversations. For clarity, purchasing staff should use the full product name and pack size rather than relying on shorthand. This helps reduce confusion when comparing Euflexxa Italian, English-labeled products, and other sodium hyaluronate lines.

Quick tip: Store receiving teams should verify carton language, lot, expiry, and syringe count before placing the pack into procedure inventory.

Key Features for Professional Use

• Contains 1% sodium hyaluronate for intra-articular viscosupplementation.
• Supplied as three sterile 2 mL prefilled syringes.
• Bioengineered, non-avian active ingredient.
• Ready-to-use syringe format for treatment-room workflows.
• Designed for administration by trained healthcare professionals.
• Lot and expiry information support traceability and chart documentation.
• Suitable for clinic inventory planning around scheduled injection series.
• Italian-labeled carton and insert for teams that source this presentation.

Handling, Storage, and Treatment-Room Workflow

Store and handle Euflexxa according to the manufacturer’s labeling and your facility’s standard operating procedures. Staff should protect sterility until point of use and avoid using any syringe or package that appears damaged, compromised, or outside acceptable handling conditions. Receiving logs, stock rotation, and lot-level tracking help maintain documentation continuity across injection visits.

Before a scheduled procedure, clinical staff commonly confirm the product, pack count, syringe integrity, expiry date, and patient-specific documentation. The prefilled syringe format can support a consistent setup process because no transfer into a separate syringe is required. Final administration technique, needle selection, injection site preparation, and imaging use remain professional clinical decisions.

Practices that run high-volume injection sessions may plan inventory by provider schedule, expected series completion, and recall timing. Uniform pack composition can reduce manual counting errors and make it easier to align purchasing with recurring clinic blocks.

Safety, Cautions, and Monitoring

Euflexxa is for intra-articular injection by qualified professionals using aseptic technique. Clinicians should review the official labeling for contraindications, warnings, and patient-specific factors before use. Treatment should be avoided when the intended injection site has active infection or skin disease, and clinicians should consider hypersensitivity history and any factors that may increase procedural risk.

Adverse events associated with knee viscosupplementation may include injection-site pain, swelling, warmth, stiffness, bruising, or transient joint discomfort. Patients should be advised according to clinic protocol about expected post-injection care and when to contact the office. Serious reactions are uncommon but require prompt clinical assessment, especially if severe pain, marked swelling, fever, or signs of infection occur after an injection.

Medication reconciliation and procedural screening remain important. Anticoagulant use, recent procedures, local skin integrity, mobility limitations, and previous reactions to intra-articular products may affect clinic planning. Documentation should include the product name, syringe volume, lot number, expiry, site, laterality, administrator, and any immediate observations required by your facility.

How Euflexxa Compares With Other Hyaluronic Acid Injections

Euflexxa belongs to the hyaluronic acid viscosupplement class, but products in this category can differ by source material, molecular characteristics, syringe configuration, labeled schedule, and market presentation. Euflexxa is non-avian and biofermented, which is a practical distinction for clinics that consider source material during formulary review. Comparisons should be made using official labeling, clinician experience, supply continuity, and documentation requirements.

Clinics reviewing alternatives often consider Orthovisc, Hyalgan, Cingal, and other viscosupplement or orthopedic injection products. For related product evaluation, see Orthovisc English, Hyalgan English, and Cingal. These links support procurement review, not therapeutic substitution without clinical approval.

For deeper class-level discussion, our articles on Euflexxa and Orthovisc, Euflexxa and Synvisc, and Hyalgan and Euflexxa outline practical differences that clinics may consider during formulary review.

Common Naming Questions

Another name clinicians may use for Euflexxa is 1% sodium hyaluronate. It may also be described more broadly as a hyaluronic acid injection or viscosupplement, although those class terms include multiple products. For procurement and charting, the brand name Euflexxa and the exact pack configuration are the clearest identifiers.

“Euflexxa in English” usually refers to the product name and active ingredient: Euflexxa, 1% sodium hyaluronate. The Italian-labeled presentation uses Italian market packaging, but the clinical product identity remains tied to the brand, active ingredient, concentration, sterile syringe format, and 3 x 2 mL pack.

Euflexxa is a hyaluronic acid injection, but it is not interchangeable with every hyaluronic acid product on operational details alone. Different brands may have different syringe counts, labeling, source materials, and administration schedules. Any product change should be reviewed by the responsible clinician and reflected in clinic documentation.

Authoritative Sources

• Euflexxa HCP information
• Manufacturer product information
• NIAMS osteoarthritis information

Sign in to source Euflexxa® (Italian) for professional clinic use and coordinate ordering around procedure schedules, documentation needs, and inventory planning.

This content is for informational purposes only and is not a substitute for professional medical advice.